Enzymotec to Report First Quarter 2015 Financial Results
April 23 2015 - 8:30AM
Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and
marketer of innovative bio-active lipid ingredients, today
announced that the Company will release financial results for the
first quarter ended March 31, 2015 on Thursday, May 7, 2015, before
the market opens. Following the release, Dr. Ariel Katz, President
and Chief Executive Officer, and Oren Bryan, Vice President and
Chief Financial Officer will host a conference call to review the
financial results.
The conference call is scheduled to begin at 8:30 a.m. ET on
Thursday, May 7, 2015. Participants should dial (877) 359-9508
(United States) or (224) 357-2393 (International) with confirmation
code 34316444 to access the live call. The
call will also be broadcast live over the Internet, hosted in the
Investors section of Enzymotec's website at
http://edge.media-server.com/m/p/ac78fbrw, and will be archived
online within one hour of its completion through May 14, 2015.
About Enzymotec Ltd.
Enzymotec Ltd. is a leading global supplier of specialty
lipid-based products and solutions. The Company develops,
manufactures and markets innovative bio-active lipid ingredients,
as well as final products, based on sophisticated processes and
technologies. For more information, visit www.enzymotec.com.
CONTACT: KCSA Strategic Communications
Jeffrey Goldberger / Tram Bui
212.896.1249 / 212.896.1290
ENZY@kcsa.com
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Jun 2024 to Jul 2024
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Jul 2023 to Jul 2024